Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ALPHA HYDROXY ACID-CONTAINING PRODUCTS "SHOULD BE REGULATED AS DRUGS"

This article was originally published in The Tan Sheet

Executive Summary

ALPHA HYDROXY ACID-CONTAINING PRODUCTS "SHOULD BE REGULATED AS DRUGS," FDA Office of Cosmetics and Colors Acting Director John Bailey, PhD, told the New York Chapter of the Society of Cosmetic Chemists April 6 at its annual spring seminar in Secaucus, N.J. "It is well established that [alpha hydroxy acids] exert an effect on the skin. I don't think that there's any doubt that under some conditions of formulations and use, AHA-containing products are affecting the structure and function of the body and they should be regulated as drugs," Bailey declared.

You may also be interested in...



People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

PS082647

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel